Media and recognition
Our work has been recognised through awards from a range of national and international organisations, and we frequently appear in consumer media to share our findings and expertise around women’s health.
Here’s some of our latest news:
 Menopausal symptom relief for women with breast cancer on the horizon after promising results published in The LancetA Monash Public Health and Preventive Medicine-led trial of a new drug known as Q-122 therapy significantly reduced the number and severity of hot flushes and night sweats in women who have been diagnosed with breast cancer. | ||
New study to see whether a skin cream can prevent heart failure in women
Women’s health expert Prof Susan Davis has been awarded a $160,000 Heart Foundation Vanguard Grant, and along with it their prestigious Ross Hohenen Award for Innovation, for a new study to evaluate the efficacy of testosterone supplementation in preventing a specific type of heart disease in post-menopausal women. | RACP College Medal awarded to renowned women’s health researcherHuge congratulations to the Head of our Women’s Health Research Program, researcher and endocrinologist Professor Susan Davis AO, on recently receiving the annual College Medal from the Royal Australian College of Physicians. | Low testosterone levels in women associated with double the risk of cardiac eventsA study led by Women’s Health Research Program leader Prof Susan Davis has challenged the traditional view that testosterone is bad for women’s hearts, showing that for women aged over 70, having low testosterone levels actually doubles the risk of a cardiac event. |
 Have healthcare professionals come to terms with menopausal hormone therapy?A concerning number of healthcare providers lack awareness or confidence around when to prescribe menopausal hormone therapy (MHT), according to a new study from our Women’s Health Research Program published in Climacteric recently. | ||
In the media
The Proof (2023)
Take a deep dive into menopause and symptom relief treatment with Prof Susan Davis on this two-hour long podcast hosted by Simon Hill.
Daily Mail (2023)
Prof Susan Davis featured in the UK's Daily Mail as an authority figure in the debate around testosterone replacement for women experiencing menopausal symptoms.
Good Weekend Magazine: Naomi, Gwyneth, Serena: The ‘menopower’ movement lights up (2023)
Prof Susan Davis features in this exploration of changing societal views of menopause.
Channel 9 News: World-first trial of testosterone to help treat early menopause (2022)
A testosterone cream will be used on women in a world-first trial to help combat some of the silent effects of early menopause.
Federal Govt. media release (2022)
A partnership grant led by Prof Susan Davis will fund the development of assessment and decision tools - integrated into existing workflows - to help GPs better identify and treat women with symptoms of menopause.
Asia-Nikkei: Asia's femtech revolution: the quest for better women's health (2022)
Prof Susan Davis featured in this exploration of how Asian women, underserved by mainstream health care, are turning to technology for health solutions.
Hope for breast cancer survivors experiencing menopausal symptoms (2022)
A new study of new non-hormonal drug therapy Q-122 significantly reduced the number and severity of hot flushes and night sweats in women who have been diagnosed with breast cancer, and for whom hormonal symptom relief is contraindicated.
Low testosterone levels in women associated with double the risk of cardiac events (2022)
A study led by Women’s Health Research Program leader Prof Susan Davis has challenged the traditional view that testosterone is bad for women’s hearts, showing that for women aged over 70, having low testosterone levels actually doubles the risk of a cardiac event.
ABC Radio National: Should it be easier for you to access the pill? (2021)
A fascinating interview about the issues around pharmacist-led renewals of oral contraceptive pills, a topic in the spotlight after the TGA reviewed a submission to change the rules.
American College of Obstetricians and Gynecologists (2021)
Learn about the work and legacy of Prof Susan Davis in this short video, produced by ACOG as part of their annual conference.
Sunrise (TV): Female Viagra nasal spray trial launched to help boost sex drive (2021)
Interview about a new study looking at a nasal spray to treat low libido in pre-menopausal women bothered by the condition.
Prizes and awards
Australasian Menopause Society Scientific Prize 2022
Dr Rakib Islam won this accolade for his outstanding contributions to our understanding of menopause, in particular this paper in The Lancet Healthy Longevity, which helped demystify the role of androgens in older women, leading to a paradigm shift in our understanding.
Australia Day Honours 2022
Prof Susan Davis AO received an Australia Day Award for distinguished service to medicine, to women's health as a clinical endocrinologist and researcher, and to medical education.
Royal Australasian College of Physicians’ College Medal 2022
Prof Susan Davis received this prestigious medal.
Heart Foundation Vanguard Grant and Ross Hohenen Award for Innovation 2022
Prof Susan Davis received funding – and this award along with it – for a new study to see whether a skin cream can prevent heart failure in women.
American Heart Association Paul Dudley White International Scholar 2021
Dr Rakib Islam won this honour for his abstract submitted to the Hypertension Scientific Sessions 2021 Conference.
Paul Dudley White International Scholar 2021
Dr Rakib Islam won this honour for his abstract submitted to the Hypertension Scientific Sessions 2021 Conference.
International Menopause Society Distinguished Service Award 2020
Prof Susan Davis won the Society's highest honour, in recognition of outstanding service to the Society.